MKC-231, a choline uptake enhancer: (2) Effect on synthesis and release of acetylcholine in AF64A-treated rats

Journal of Neural Transmission

Volumn 115, Issue 7, 2008, Pages 1027-1035

  Takashina, Ken ^a   Bessho, Tomoko ^a   Mori, Reiko ^a   Eguchi, Junichi ^a   Saito, Ken Ichi ^a  

^a MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

Author keywords

Acetyl choline (ACh); AF64A; High affinity choline uptake (HACU); Microdialysis; MKC 231; Radioimmunoassay

Indexed keywords

2 (2 OXO 1 PYRROLIDINYL) N (5,6,7,8 TETRAHYDRO 2,3 DIMETHYLFURO[2,3 B]QUINOLIN 4 YL)ACETAMIDE; ACETYLCHOLINE; CHOLINE UPTAKE ENHANCER; CHOLINESTERASE INHIBITOR; ETHYLCHOLINE MUSTARD AZIRIDINIUM; POTASSIUM ION; TACRINE;

ACETYLCHOLINE RELEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CHOLINE UPTAKE; CONTROLLED STUDY; DRUG RELEASE; DRUG SYNTHESIS; HIPPOCAMPUS; IN VITRO STUDY; IN VIVO STUDY; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT;

ACETYLCHOLINE; ANALYSIS OF VARIANCE; ANIMALS; AZIRIDINES; CHOLINE; CHOLINESTERASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; HIPPOCAMPUS; MALE; MICRODIALYSIS; NEUROMUSCULAR BLOCKING AGENTS; POTASSIUM; QUINOLINES; RATS; RATS, WISTAR; SYNAPTOSOMES; TACRINE; TRITIUM;

EID: 46649106266     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-008-0048-1     Document Type: Article

References (28)

1. Aarsland D, Mosimann UP, McKeith IG (2004) Role of cholinesterase inhibitors in Parkinson's disease and dementia with Lewy bodies. J Geriatr Psychiatry Neurol 17:164-171
2. Bessho T, Takashina K, Tabata R, Oshima C, Chaki H, Yamabe H, Egawa M, Tobe A, Saito K-I (1996) Effects of the novel high affinity choline uptake enhancer 2-(2-oxopyrrolidin-1-yl)-N-(2, 3-dimethyl-5, 6, 7, 8-tetrahydrofuro[2, 3-b]quinolin-4-yl) acetoamide on deficits of water maze learning in rats. Arzneimittelforschung 46:369-373
3. Buyukuysal RL, Holmes T, Wurtman RJ (1991) Interactions of 3, 4-diaminopyridine and choline in stimulating acetylcholine release and protecting membrane phospholipids. Brain Research 541:1-6
4. Chrobak JJ, Hanin I, Schmechel TJ, Walsh TJ (1988) AF64A-induced working memory impairment: behavioral, neurochemical and histological correlates. Brain Res 463:107-117
5. Coleman PD, Yao PJ (2003) Synaptic slaughter in Alzheimer's disease. Neurobiol Aging 24:1023-1027
6. Collerton D (1986) Cholinergic function and intellectual decline in Alzheimer's disease. Neuroscience 19(1):1-28
7. De Bore P, Westerink BHC, Horn AS (1990) The effects of acetylcholine from the striatum in vivo: interaction with autoreceptor responses. Neurosci Lett 116:357-360
8. Fisher A, Mantione CR, Abraham DJ, Hanin I (1982) Long-term central cholinergic hypofunction induced in mice by ethylcholine aziridinium ion (AF64A) in vivo. J Pharmacol Exp Ther 222:140-145
9. Gower AJ, Rousseau D, Jamsin P, Gobert J, Hanin I, Wulfert E (1989) Behavioral and histological effects of low concentrations of intraventricular AF64A. Eur J Pharmacol 166:271-281
10. Hortnagl H (1994) AF64A-induced brain damage and its relation to dementia. J Neural Transm Suppl 44:245-257
11. Jarrard LE, Kant GJ, Meyerhoff JL, Levy A (1984) Behavioral and neurochemical effects of intraventricular AF64A administration in rats. Pharmacol Biochem Behav 21:273-80
12. Kasa P, Rakonczay Z, Gulya K (1997) The cholinergic system in Alzheimer's disease. Prog Neurobiol 52:511-535
13. Kawashima K, Sato A, Yoshizawa M, Fujii T, Fujimoto K and Suzuki T (1994) Effects of the centrally acting cholinesterase inhibitors tetrahydroaminoacridine and E2020 on the basal concentration of extracellular acetylcholine in the hippocampus of freely moving rats. Naunyn-Schmiedeberg's Arch Pharmacol 350: 523-528
14. Kawashima K, Hayakawa T, Kashima Y, Suzuki T, Fujimoto K, Oohata H (1991) Determination of acetylcholine release in the striatum of anesthetized rats using in vivo microdialysis and radioimmunoassay. J Neurochem 57:882-887
15. 3H) Hemicholinium-3 binding sites in postmortem brains of human patients with Alzheimer's disease and multi-infarct dementia. Exp Gerontol 30:125-136
16. Leventer S, McKeag D, Clancy M, Wulfert E, Hanin I (1985) Intracerebroventricular administration of ethylcholine mustard aziridinium ion (AF64) reduces release of acetylcholine from rat hippocampal slices. Neuropharmacology 24:453-459
17. Murai S, Saito H, Abe E, Masuda Y, Odashima J, Itoh T (1994) MKC-231, a choline uptake enhancer, ameliorates working memory deficits and decreased hippocampal acetylcholine induced by ethylcholine aziridinium ion in mice. J Neural Trasm 98:1-13
18. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates, 2nd ed. Academic Press, New York
19. Potter PE, Nitta S (1993) Alterations in modulation of acetylcholine release following lesion of hippocampal cholinergic neurons with the neurotoxin AF64A. Neuropharmacology 32:519-526
20. 3H-hemicholinium-3. J Neural Transm 8:161-169
21. Rylett RJ, Ball MJ, Colhoun EH (1983) Evidence for high affinity choline transport in synaptosomes prepared from hippocampus and neocortex of patients with Alzheimer's disease. Brain Res 289:169-175
22. Scheff SW, Price DA (2003) Synaptic pathology in Alzheimer's disease: a review of ultrastructural studies. Neurobiol Aging 24(8):1029-1046
23. Schliebs R, Arendt T (2006) The significance of the cholinergic system in the brain during aging and in Alzheimer's disease. J Neural Transm 113(1):1625-1644
24. Sims NR, Bowen DM, Allen SJ, Smith CCT, Neary D, Thomas DJ, Davison AN (1983) Presynaptic cholinergic dysfunction in patients with dementia. J Neurochem 40(2):503-509
25. Smith G (1988) Animal models of Alzheimer's disease: experimental cholinergic denervation. Brain Research Review 13:103-118
26. Stip E, Chouinard S, Boulay LJ (2005) On the trail of a cognitive enhancer for the treatment of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 29:219-232
27. Terry AV Jr., Buccafusco JJ (2003) The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: Recent challenges and their implications for novel drug development. J Pharmacol Exp Ther 306:821-827
28. Ulus IH, Wurtman RJ, Mauron C, Blusztajn JK (1989) Choline increases acetylcholine release and protect against the stimulation-induced decrease in phosphatide levels within membrane of rat corpus striatum. Brain Research 484:217-227